The fragility of development, manufacture, supply and demand in healthcare product manufacture, and the anticipation of more complex trading arrangements that might impact the supply chain post Brexit will be discussed at a symposium in London organised by the University of the West of England (UWE Bristol) on 14 October.
‘Navigating Regulatory Requirements for Redistributed Manufacturing in Healthcare’ conference will take place at the Medical Research Council in Kemble Street, London from 09:00 to 17:00.
UWE Bristol is leading a research network called ‘Redistributed Manufacturing in Healthcare network’ (RiHN) that is working to identify and publicise breakthrough achievements and new systems technologies that will make a positive contribution to the future of point-of-care manufacturing.
“Dr Wendy Phillips, from UWE Bristol and RiHN project lead, explains, “The event will contribute towards defining a vision for a regulatory framework that supports applications within the redistributed manufacturing. Cost control is a priority for the NHS. The event will look at how innovative products, whose unusual character means they do not confirm to existing regulatory requirements, can access the UK healthcare system, enabling more cost-effective treatment of conditions that would otherwise remain untreatable or would require long-term care.
“In addition the event will also consider, Post-Brexit, how much latitude is there now to define our own UK regulatory framework and to what extent is it desirable to achieve international harmonisation of standards.”
Expert speakers include regulators, academia, industry and professional organisations. The key focus will be on the regulatory aspects of distributed models of manufacturing. Clinicians, academia and industry expertise will be shared at this forum that aims to help position the UK at the forefront of healthcare manufacturing.
This event is part of a wider research programme via the RiHN network run by a team of multi-disciplinary academic researchers from six UK universities, and is sponsored by the Engineering and Physical Sciences Research Council.
The conference will be of interest to professionals involved in the re-distribution of manufacturing in healthcare. This includes academics conducting early stage research or in the formative stages of clinical trials; companies at the point of commercialising a new technology/process and those reviewing or procuring new solutions that involve bringing manufacturing closer to clinical need or use.
The event will help identify and publicise breakthrough achievements and novel systems technologies that will significantly impact the future of point-of-care manufacturing.
The outputs will be compiled into a public white paper, which aims to inform future funding and investment in this area.